Claritas Pharmaceuticals Inc V.CLAS.H

RE:The U.S. FDA has recommended that Kalytera

[MyKnight]

Very happy for this gentlemen, imagine after 2 years of being sick, the product gave him a chance at a better life.... this being said, that could be thru for all GVHD client that are still alive...

Yes I want to make a fortune with Kaly, but when you get testomony like this, it does bring another view at the product.

“An article published this month in Blood reported the case of a 35 year old patient who developed a variant of skin GVHD that is considered to be particularly aggressive, difficult to control, and which carries a poor prognosis. This patient was treated with a cannabinoid solution comparable to a 300-mg. dose of Kalytera’s product. As reported in the article, there was a definite response within 3 months, allowing discontinuation of other treatments, and by 2-years post bone marrow transplant, the patient’s skin issues had resolved with only mild itching and flakiness. (A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Versus Host Disease (GVHD), Tsiporah B. Shore, MD, Jess B. Ryan, ANP, Michael B. Samuel, MD, November 13, 2019, Blood, Volume 134, Issue Supplement_1).
Read more at https://stockhouse.com/companies/bullboard?symbol=v.kly&postid=30396887#wqiTxWZrl5bbthdX.99